Walker Luke Nathaniel - Form 4 Filing

Luke Nathaniel Walker, a director at Context Therapeutics Inc. (CNTX), acquired 45,000 stock options on June 24, 2026. These options, with an exercise price of $0.576 per share, are exercisable on the earlier of June 24, 2027, or the Issuer's 2027 annual meeting, contingent upon continued service. The options are set to expire on June 23, 2036. Following this transaction, Walker directly owns 45,000 shares of common stock underlying these options. The filing was made on June 26, 2026.